Date: 2015-10-14
Type of information: Establishment of a new subsidiary in the EU
Compound:
Company: Merck KGaA (Germany)
Therapeutic area:
Type agreement: brand identity
Action mechanism:
Disease:
Details: * On October 14, 2015, Merck KGaA announced the relaunch of its brand identity. The fundamental revision of the visual appearance as well as the introduction of a new logo reflect the transformation into a global science and technology company. At the same time, the brand architecture at business level has been simplified. Outside the United States and Canada, the company will operate uniformly as Merck. With the introduction of the new brand design, the previously independent divisional brands Merck Serono and Merck Millipore will be eliminated. In the future, Merck Serono will operate as the biopharmaceutical business of Merck, and Merck Millipore as the life science business of Merck KGaA.
Merck KGaAholds the rights to the Merck name and brand globally. The only exceptions are the United States and Canada. The company will therefore continue to operate in these two countries as EMD Serono in the biopharmaceutical business, as EMD Performance Materials in the high-tech materials business, as well as EMD Millipore in the life science business up until the planned acquisition of Sigma-Aldrich has been completed.
Financial terms:
Latest news:
